EUVIMEDEUVIMED entdecken
Open Access

REV-ERB regulates RORγt+ regulatory T cell specification and function through the Bhlhe40-c-Maf axis

Xianting Hu iD, Zhi Liu iD, Yao Li iD, Yannan You iD, Kaiye Yue iD, Yuqiong Liang iD, Chin-San Loo iD, Jingting Yu iD, Matthias Leblanc iD, Dehui Wang iD, Huabin Li iD, Ye Zheng iD

Journal of Experimental Medicine · 2026

DOI: 10.1084/jem.20241463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Xianting Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Eye and ENT Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 1, Group F, Member 3, Proto-Oncogene Proteins c-maf, T-Lymphocytes, Regulatory, Basic Helix-Loop-Helix Proteins. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Foxp3+ regulatory T (Treg) cells co-expressing RORγt adopt specialized functions to restrain intestinal inflammation. However, despite extensive characterization, the factors governing RORγt+Foxp3+ Treg specialization remain unclear. Here, we report that transcriptional repressor REV-ERB is critical for the differentiation and function of colonic RORγt+Foxp3+ Treg cells. REV-ERB deficiency exacerbates both TNBS- and oxazolone-induced intestinal inflammation. Mechanistically, REV-ERB promotes RORγt expression through suppressing the expression of transcriptional repressor Bhlhe40, which in turn inhibits c-Maf, a key factor promoting colonic RORγt+Foxp3+ Treg differentiation and function. Moreover, this Bhlhe40-c-Maf axis downstream of REV-ERB also regulates the expression of core colonic Treg signature genes including IL-10 and CTLA-4, while REV-ERB additionally safeguards RORγt+Foxp3+ Treg functional stability by directly suppressing proinflammatory cytokine IL-17A production. Collectively, the present study identifies that REV-ERB along with the downstream Bhlhe40-c-Maf axis jointly controls the RORγt+Foxp3+ Treg differentiation and suppressive function, suggesting that modulating their activities may strengthen RORγt+Foxp3+ Treg function to ameliorate inflammatory bowel diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 1, Group F, Member 3Proto-Oncogene Proteins c-mafT-Lymphocytes, RegulatoryBasic Helix-Loop-Helix ProteinsAnimalsMiceCell DifferentiationMice, Inbred C57BLColitisForkhead Transcription FactorsMice, KnockoutSignal TransductionHomeodomain Proteins

Substanzen

Nuclear Receptor Subfamily 1, Group F, Member 3Proto-Oncogene Proteins c-mafBasic Helix-Loop-Helix ProteinsForkhead Transcription FactorsHomeodomain ProteinsRorc protein, mouseMaf protein, mouseBhlhe40 protein, mouseFoxp3 protein, mouse

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, Eye and ENT Hospital, Fudan University, Shanghai, China.
  • NOMIS Center for Immunology and Microbial Pathogenesis, Salk Institute for Biological Studies , La Jolla, CA, USA.
  • Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China.
  • Razavi Newman Integrative Genomics and Bioinformatics Core, Salk Institute for Biological Studies , La Jolla, CA, USA.
  • Wake Forest Baptist Health , Winston-Salem, NC, USA.

ORCID-Profile: Xianting Hu, Zhi Liu, Yao Li, Yannan You, Kaiye Yue, Yuqiong Liang, Chin-San Loo, Jingting Yu, Matthias Leblanc, Dehui Wang, Huabin Li, Ye Zheng

Förderung

  • NIH HHS
  • NCI NIH HHS
  • National Natural Science Foundation of China
  • NOMIS Foundation
  • NIA NIH HHS
  • Sol Goldman Charitable Trust
  • Salk Institute
  • Noncommunicable Chronic Diseases-National Science and Technology

Zitieren

APA

Hu, X., Liu, Z., Li, Y., You, Y., Yue, K., Liang, Y., Loo, C. S., Yu, J., Leblanc, M., Wang, D., Li, H., & Zheng, Y. (2026). REV-ERB regulates RORγt+ regulatory T cell specification and function through the Bhlhe40-c-Maf axis. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20241463

Vancouver

Hu X, Liu Z, Li Y, You Y, Yue K, Liang Y, et al. REV-ERB regulates RORγt+ regulatory T cell specification and function through the Bhlhe40-c-Maf axis. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20241463

BibTeX
@article{Hu2026,
  author = {Hu, Xianting and Liu, Zhi and Li, Yao and You, Yannan and Yue, Kaiye and Liang, Yuqiong and Loo, Chin-San and Yu, Jingting and Leblanc, Matthias and Wang, Dehui and Li, Huabin and Zheng, Ye},
  title = {REV-ERB regulates RORγt+ regulatory T cell specification and function through the Bhlhe40-c-Maf axis},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  doi = {10.1084/jem.20241463}
}
Kostenlos starten →